Ratings Lincoln National Corporation

Equities

LNC

US5341871094

Market Closed - Nyse Other stock markets 21:00:02 29/04/2024 BST			5-day change	1st Jan Change
28.01 ^USD	+0.72%		-2.51%	+3.86%

04-11	Wells Fargo Adjusts Price Target on Lincoln National to $28 From $26, Keeps Equalweight Rating	MT
04-11	Evercore ISI Raises Price Target on Lincoln National to $35 From $33, Maintains In-Line Rating	MT

Summary

The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.58 for the 2024 fiscal year.
The company appears to be poorly valued given its net asset value.
Given the positive cash flows generated by its business, the company's valuation level is an asset.
This company will be of major interest to investors in search of a high dividend stock.
Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

Weaknesses

For the past year, analysts have significantly revised downwards their profit estimates.
The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Life & Health Insurance

	1st Jan change	Capi.	ESG Refinitiv
LINCOLN NATIONAL CORPORATION	+3.86%	4.73B	B+
AXA	+15.94%	79.51B	B-
METLIFE, INC.	+8.42%	50.22B	B+
AFLAC INCORPORATED	+2.47%	48.11B	B
MANULIFE FINANCIAL CORPORATION	+10.21%	42.2B	B+
PRUDENTIAL FINANCIAL, INC.	+7.93%	39.71B	B+
GENERALI	+20.02%	37.78B	B
SUN LIFE FINANCIAL INC.	+2.62%	30.07B	B
GREAT-WEST LIFECO INC.	-7.27%	27.56B	B-
PRUDENTIAL PLC	-16.43%	24.71B	A-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes